drugset / Trial / NCT01675622

Immediate-Release Oxycodone Capsules Study in Cancer Pain

NCT01675622

Phase 3 Completed 242 enrolled Mundipharma (China) Pharmaceutical Co. Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The efficacy of dose titration of OxyNorm™(Oxycodone) immediate-release capsules versus morphine immediate-release tablets in the treatment of cancer pain.

Timeline

Start
2011-01
Primary completion
2012-06
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 10 mg Oral
Comparator Morphine Other / unclassified 20 mg Oral
Subject Oxycodone Other / unclassified 5 mg
Subject Oxycodone Other / unclassified 10 mg
Subject Oxycodone Other / unclassified 20 mg

Indications